Skip to content

Effects of Citrulline on Gut Functioning During Excercise

Effects of Citrulline on Gut Functioning During Excercise

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01239303
Enrollment
30
Registered
2010-11-11
Start date
2010-12-31
Completion date
2012-02-29
Last updated
2011-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal, Hypoperfusion, Gut Damage

Brief summary

During exercise, splanchnic perfusion is compromised, resulting in organ damage in healthy individuals. Improving the availability of NO might result increase splanchnic perfusion and prevent organ damage during exercise.

Detailed description

The gastrointestinal (GI) tract plays an important role in the human body. The wall of the GI system regulates digestion and absorption of nutrients and it also has a very important function as a barrier between internal and external environment. The penetration of harmful substances and microbiota of the GI lumen (external environment) to the systemic circulation (internal environment) depends on this barrier. Previous studies have shown that exercise in healthy subjects provides hypoperfusion of the splanchnic area, resulting in intestinal damage, increased small intestinal permeability and liver damage. Similar splanchnic hypoperfusion occurs in patients with compromised circulation. During episodes of splanchnic hypoperfusion, the de novo synthesis of nitric oxide (nitric oxide, NO) from arginine is compromised. This impaired NO synthesis may play a role in the development of organ dysfunction during exercise. L-citrulline administration, a precursor of arginine and NO, may result in improved NO availability and organ perfusion, thereby preventing organ damage.

Interventions

DIETARY_SUPPLEMENTCitrulline

single dose

DIETARY_SUPPLEMENTalanine

single dose

Sponsors

Top Institute Food and Nutrition
CollaboratorOTHER
Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* male * age 18-35 years

Exclusion criteria

* not healthy * use of medication or related products * alcohol misuse * smoking

Design outcomes

Primary

MeasureTime frame
GI perfusion2 hours
gut damage5 hours
microcirculation5 hours

Secondary

MeasureTime frame
liver damage5 hours
kidney damage5 hours
amino acid analysis5 hours

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026